Pilot study for a Swedish Centre for Cell Therapy
|Coordinator||RISE RESEARCH INSTITUTES OF SWEDEN AB - SP Sveriges Tekniska Forskningsinstitut AB, Stockholm|
|Funding from Vinnova||SEK 2 900 000|
|Project duration||December 2016 - February 2018|
Purpose and goal
The overall objective of the project, to strengthen Sweden’s position and capabilities on ATMP development, has been achieved by mapping of the Swedish ATMP landscape, identifying and analyzing the needs and challenges, highlighting the area and existing Swedish infrastructures and competencies, and networking with international expertise. Overall, this has strengthened national collaboration within the area and contributed to establishing a national Centre for Advanced Medical Products (CAMP).
Expected results and effects
Needs identified within the project will be addressed by collaborations in the national ATMP centre CAMP. Long term effects will be more efficient ATMP development in Sweden and a growing segment of Life Science industry developing ATMPs with the support of an ecosystem of service providers. This in turn will make Sweden more attractive for foreign investments. In parallel, patients and the healthcare system will benefit from new and improved treatments.
Planned approach and implementation
The project consisted of five work packages: (1) mapping of projects and actors, (2) mapping of needs, infrastructures and competencies, (3) support to selected project cases, (4) study for a Swedish strategy for Gene Therapy, and (5) project management, coordination and dissemination. The work was been carried out in dialogue a wide range of national actors and stakeholders and international experts, and in coordination the CAMP and Swelife-ATMP initiatives.